These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 14987350

  • 1. Caspofungin in a pediatric patient with persistent candidemia.
    Wertz KK, Pretzlaff RK.
    Pediatr Crit Care Med; 2004 Mar; 5(2):181-3. PubMed ID: 14987350
    [Abstract] [Full Text] [Related]

  • 2. Experience with caspofungin in the treatment of persistent fungemia in neonates.
    Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Bedard M.
    J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of candidemia on caspofungin therapy: a case report.
    Cheung C, Guo Y, Gialanella P, Feldmesser M.
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F, Spreghini E, Fothergill AW, Arzeni D, Greganti G, Giannini D, Rinaldi MG, Scalise G.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
    McGee WT, Tereso GJ.
    Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
    Olver WJ, Scott F, Shankland GS.
    Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
    [Abstract] [Full Text] [Related]

  • 9. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G, Figgitt D.
    Drugs; 2003 Nov; 63(20):2235-63. PubMed ID: 14498760
    [Abstract] [Full Text] [Related]

  • 10. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
    Pan SC, Hsieh SM, Chang SC, Lee HT, Chen YC.
    Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
    [Abstract] [Full Text] [Related]

  • 11. Antifungals in systemic neonatal candidiasis.
    Frattarelli DA, Reed MD, Giacoia GP, Aranda JV.
    Drugs; 2004 Dec; 64(9):949-68. PubMed ID: 15101785
    [Abstract] [Full Text] [Related]

  • 12. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG.
    Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
    [Abstract] [Full Text] [Related]

  • 13. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ, Hille D, Sable CA, Kartsonis NA.
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [Abstract] [Full Text] [Related]

  • 14. Caspofungin for refractory candidemia in neonates.
    Manzar S, Kamat M, Pyati S.
    Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
    [No Abstract] [Full Text] [Related]

  • 15. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.
    N Engl J Med; 2004 Sep 30; 351(14):1391-402. PubMed ID: 15459300
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F, Castronovo A, Regoli D, De Curtis M, Manzoni P.
    Pediatr Infect Dis J; 2009 May 30; 28(5):452. PubMed ID: 19295457
    [No Abstract] [Full Text] [Related]

  • 17. Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis.
    Wingard JR, Wood CA, Sullivan E, Berger ML, Gerth WC, Mansley EC.
    Clin Ther; 2005 Jun 30; 27(6):960-9. PubMed ID: 16117996
    [Abstract] [Full Text] [Related]

  • 18. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.
    Clin Infect Dis; 2007 Oct 01; 45(7):883-93. PubMed ID: 17806055
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT.
    Antimicrob Agents Chemother; 2005 Dec 01; 49(12):4895-902. PubMed ID: 16304150
    [Abstract] [Full Text] [Related]

  • 20. Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.
    van Hal SJ, Stark D, Harkness J, Marriott D.
    Emerg Infect Dis; 2008 Feb 01; 14(2):327-9. PubMed ID: 18258133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.